Drug Type Aptamer drug conjugates |
Synonyms ONC 02, ONC-02 |
Target |
Mechanism FLT3 modulators(Tyrosine-protein kinase receptor FLT3 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Centauri Therapeutics Ltd.Startup |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leukemia | Preclinical | GB | - | |
Acute Myeloid Leukemia | Discovery | GB | Centauri Therapeutics Ltd.Startup | 05 Apr 2019 |